GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Il1b | multiple interactions | EXP | | 6480464 | CTD | fisetin inhibits the reaction [IL1B protein results in decreased expression of ACAN protein]; fisetin inhibits the reaction [IL1B protein results in decreased expression of BCL2 protein]; fisetin inhibits the reaction [IL1B protein results in decreased expression of COL2A1 protein]; fisetin inhibits the reaction [IL1B protein results in decreased expression of SIRT6 protein]; fisetin inhibits the reaction [IL1B protein results in increased expression of ADAMTS5 protein]; fisetin inhibits the reaction [IL1B protein results in increased expression of ARPC5 protein]; fisetin inhibits the reaction [IL1B protein results in increased expression of BAX protein]; fisetin inhibits the reaction [IL1B protein results in increased expression of CDKN1A protein]; fisetin inhibits the reaction [IL1B protein results in increased expression of H2AX protein]; fisetin inhibits the reaction [IL1B protein results in increased expression of MMP13 protein]; fisetin inhibits the reaction [IL1B protein results in increased expression of NOS2 protein]; fisetin inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein] | PMID:38278314 | Il1b | multiple interactions | ISO | IL1B (Homo sapiens) | 6480464 | CTD | fisetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA]; fisetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL1B protein] | PMID:18958421 | | ||||||||||||||||||||||
| Go Back to source page | Continue to Ontology report |